Co-Authors
This is a "connection" page, showing publications co-authored by Yueping Li and Linghua Li.
Connection Strength
1.671
-
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med (N Y). 2020 Dec 18; 1(1):105-113.e4.
Score: 0.883
-
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China. J Clin Virol. 2020 12; 133:104661.
Score: 0.227
-
Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients. Virology. 2020 12; 551:26-35.
Score: 0.226
-
Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. J Med Virol. 2021 02; 93(2):794-802.
Score: 0.224
-
Prognostic Factors for COVID-19 Pneumonia Progression to Severe Symptoms Based on Earlier Clinical Features: A Retrospective Analysis. Front Med (Lausanne). 2020; 7:557453.
Score: 0.057
-
Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China. Open Forum Infect Dis. 2020 Jun; 7(6):ofaa187.
Score: 0.055